Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study

BACKGROUND: The use of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) carries a risk of renal function deterioration in cirrhotic patients with ascites. However, whether the long-term use of ACEis/ARBs is safe in cirrhotic patients without ascites remains u...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Wei-Fan, Yu, Shi-Hang, Lin, Jaw-Town, Wu, Jaw-Ching, Hou, Ming-Chih, Huang, Yi-Hsiang, Wu, Chun-Ying, Peng, Cheng-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811787/
https://www.ncbi.nlm.nih.gov/pubmed/31687012
http://dx.doi.org/10.1155/2019/1743290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811787/
https://www.ncbi.nlm.nih.gov/pubmed/31687012
http://dx.doi.org/10.1155/2019/1743290

Ejemplares similares